Analyst Ratings — September 15, 2026 — Midday Update — Last 24 Hours (Pacific Time)

Executive Summary

Analyst activity over the past 24 hours skewed decisively bullish, with upgrades and initiations outnumbering downgrades by a wide margin. Guggenheim dominated the session with a sweeping defense and aerospace initiation blitz, while UBS, Needham, and Stifel were also highly active across tech, healthcare, and consumer. Key themes driving calls include AI-driven demand momentum (Palantir, AMD, Qualcomm), defense spending tailwinds, margin pressure in consumer discretionary (Dave & Buster's, Thor Industries), and a notable wave of new coverage across industrials and biotech.

Analyst Action Breakdown

Net Sentiment: 🟢 Bullish
Upgrades outnumber downgrades nearly 2-to-1, and the large volume of bullish initiations — particularly Guggenheim's defense sweep and multiple buy-rated new coverage calls — tilts overall sentiment clearly positive. PT cuts are largely concentrated in consumer discretionary and a handful of idiosyncratic stories, while PT raises span AI, defense, biotech, and energy.

Top Analyst Calls

🟢 UBS → Palantir (PLTR) — PT Raised to $250 from $220, maintains Buy

• Strong AI demand momentum continues to drive upward revisions for the data analytics firm.

🟢 Berenberg → Eli Lilly (LLY) — Upgraded to Buy from Hold, PT raised to $1,400

• Obesity drug strength underpins the upgrade as GLP-1 franchise momentum remains robust.

🟢 RBC Capital → ResMed (RMD) — Upgraded to Outperform from Sector Perform, PT raised

• Sleep device growth outlook improving, prompting a conviction upgrade from RBC.

🟢 Guggenheim → Northrop Grumman (NOC) — Initiated at Buy, PT $612

• Part of a broad defense initiation wave citing strong defense spending tailwinds.

🟢 Guggenheim → Kratos Defense (KTOS) — Initiated at Buy

• Defense growth thesis drives fresh bullish coverage on the autonomous systems specialist.

🟢 Guggenheim → New York Times (NYT) — Upgraded to Buy from Neutral, PT raised to $82

• Digital growth acceleration prompts a conviction shift from the sidelines.

🟢 Oppenheimer → Etsy (ETSY) — Upgraded to Outperform from Perform, PT $90

• AI-driven search improvements seen as a meaningful catalyst for the marketplace platform.

🟢 JPMorgan → Middleby (MIDD) — Upgraded to Overweight from Neutral, PT raised to $147

• Portfolio focus and strategic clarity drive the upgrade from a top-tier firm.

🟢 Bernstein → Agilon Health (AGL) — Upgraded to Outperform from Market Perform

• Turnaround progress gaining credibility with one of the Street's more influential voices.

🟢 Piper Sandler → AMD (AMD) — Reiterated Overweight, PT $600

• Strong AI demand continues to anchor one of the Street's most bullish semiconductor calls.

🔴 BMO Capital → Dave & Buster's (PLAY) — PT Cut to $13 from $22, maintains Outperform

• Significant margin pressure drives a steep 41% price target reduction.

🔴 JPMorgan → Rapid7 (RPD) — Downgraded to Underweight from Neutral, PT $12

• Transition concerns prompt a rare bearish call from JPMorgan on the cybersecurity name.

🔴 UBS → Comcast (CMCSA) — PT Cut to $27 from $32, maintains Neutral

• Ongoing broadband subscriber losses weigh on the outlook for the cable giant.

🔴 Morgan Stanley → EHang (EH) — Downgraded to Equalweight from Overweight, PT lowered

• Regulatory uncertainty clouds the eVTOL pioneer's near-term path forward.

🟢 Mizuho → Immix Biopharma (IMMX) — PT Raised to $26 from $15, maintains Outperform

• A 73% price target increase on expansion progress makes this one of the session's boldest biotech calls.

Firm Activity Summary

Guggenheim — 20 calls (15 bullish, 3 neutral, 2 bearish)

• Initiated Buy: NOC, KTOS, CW, BWXT, LHX, HXL, KRMN, DRS, AADX, MRCY, HWM, WWD, RBC, NBTX
• Initiated Neutral: SARO, TDG, AIR, RDW, HEI, YSS, VSEC
• Upgraded: NYT (Buy from Neutral)
• PT Cut: IONS; PT Raise: IVA; Reiterated Neutral: WEN

UBS — 9 calls (5 bullish, 3 neutral, 1 bearish)

• PT Raised: PLTR, BBNX
• PT Cut: CMCSA, PLAY
• Reiterated Buy: SRRK, DT, ACN, AZO, FIX
• Reiterated Neutral: HUBG, PLCE

Stifel — 8 calls (5 bullish, 3 neutral)

• Reiterated Buy: OFIX, CLPT, HLMN, KMTS, CTNM
• Reiterated Hold: LOW, SITE, HD
• Initiated Buy: IBP
• Reiterated Hold: SION

Needham — 8 calls (7 bullish, 1 neutral)

• PT Raised: TDY, ZBRA, SEI, ELMT
• PT Cut: SYM, EOS Energy
• Reiterated Buy: VCYT
• Raised: Solaris Energy (SEI)

DA Davidson — 7 calls (6 bullish, 1 neutral)

• Reiterated Buy: CLBT, GMTL, CTOS, ALM, CR
• PT Cut: LIF (Neutral)
• Reiterated Buy: multiple

Cantor Fitzgerald — 7 calls (5 bullish, 2 neutral)

• Reiterated Overweight: NYXH, MDXG, NPCE, HOOD
• Initiated Overweight: IOT, BSY, PCOR
• Initiated Neutral: ADSK

Citizens — 7 calls (3 bullish, 2 neutral, 1 bearish, 1 upgrade)

• Reiterated Outperform: ALLO, MSFT, BNTC
• Reiterated Market Perform: SION, PLAY, KREF
• PT Cut: ENVA
• Upgraded: RLGT
• Downgraded: CLLS

Piper Sandler — 4 calls (4 bullish)

• Reiterated Overweight: KMTS, GH, AMD
• PT Raised: SRRK

H.C. Wainwright — 3 calls (3 bullish)

• PT Raised: SRRK; Reiterated Buy: DFTX, CRBP

BMO Capital — 5 calls (3 bullish, 2 bearish)

• PT Cut: PLAY, THO
• PT Raised: DT
• Upgraded: ENB (Outperform)
• Reiterated Outperform: OBE

RBC Capital — 5 calls (2 bullish, 2 neutral, 1 upgrade)

• Upgraded: RMD
• Reiterated Sector Perform: COST, MCD
• Initiated Sector Perform: PPL, CNP
• Initiated Outperform: KRKNF

Mizuho — 4 calls (3 bullish, 1 bearish)

• PT Raised: IMMX
• PT Cut: GLW
• Reiterated Outperform: FIVE, ORCL
• Semiconductor pullback note: bullish on Micron and others

StoneX — 4 calls (3 bullish, 1 neutral)

• Reiterated Buy: QCOM, TSEM, INDI, AQMS (Speculative Buy), BFRI (Speculative Buy)
• Reiterated Hold: PLAY

Canaccord Genuity — 2 calls (2 bullish)

• Reiterated Buy: HITI; PT Raised: DFTX

JPMorgan — 3 calls (2 bullish, 1 bearish)

• Upgraded: MIDD; Initiated Overweight: DAVE; Downgraded: RPD

Berenberg — 2 calls (2 bullish)

• Upgraded: LLY (Buy), ANTO (Buy)

Raymond James — 2 calls (1 bullish, 1 neutral)

• Reiterated Strong Buy: VERA; Downgraded: ASND (Outperform from Strong Buy)

Jefferies — 2 calls (2 bullish)

• PT Raised: SR; Initiated Buy: JAN

Oppenheimer — 2 calls (2 bullish)

• Upgraded: ETSY; Initiated Outperform: VSH

William Blair — 2 calls (1 bullish, 1 bearish)

• Upgraded: SEIC; Downgraded: BWIN

Sector Trends

Defense & Aerospace — Overwhelmingly Bullish. Guggenheim's mass initiation of 14+ defense and aerospace names — including Northrop Grumman, L3Harris, Kratos Defense, BWX Technologies, Howmet Aerospace, and Leonardo DRS — is the single biggest sector story of the session. The firm's bullish thesis centers on sustained defense spending tailwinds, nuclear energy growth, and robust demand for advanced aerospace components. Needham also raised targets on Teledyne and Elmet Group on defense-related catalysts, reinforcing the sector's strong analyst consensus.

Technology & AI — Broadly Bullish with Selective Caution. AI demand remains the dominant positive catalyst, with Piper Sandler reiterating AMD at $600, UBS raising Palantir to $250, StoneX backing Qualcomm on data center growth, and Mizuho flagging the semiconductor pullback as a buying opportunity. Rosenblatt initiated Nokia at Buy citing AI infrastructure growth. The one notable exception is JPMorgan's downgrade of Rapid7 to Underweight, reflecting concern about cybersecurity transition risk rather than AI broadly.

Consumer Discretionary — Under Pressure. Dave & Buster's (PLAY) drew cuts from BMO (to $13 from $22), UBS (to $9 from $12), and holds from StoneX and Citizens — a rare multi-firm pile-on signaling genuine fundamental deterioration after an earnings miss. Thor Industries and MasterCraft Boat also saw price target reductions on softer retail trends. Meanwhile, Ulta Beauty received a Wells Fargo upgrade and Etsy an Oppenheimer upgrade, suggesting selectivity within the space rather than a blanket sector call.

Market Implications

The sheer volume of bullish defense initiations from Guggenheim signals growing institutional conviction that defense budgets will remain elevated — a meaningful tailwind for names like Northrop Grumman, L3Harris, and Kratos that may not yet be fully priced in. Investors rotating into defense as a relative safe haven amid macro uncertainty would find broad analyst support here. The Needham and StoneX calls on Teledyne and Qualcomm add further weight to the defense-tech crossover theme.

AI remains the most durable positive catalyst across sectors. The Palantir PT raise to $250, AMD's $600 Overweight reiteration, and Comfort Systems USA's Buy reiteration on data center strength all point to analysts still finding room to run in AI infrastructure plays. Mizuho's explicit call to buy the semiconductor dip is particularly notable — suggesting the recent pullback is viewed as tactical noise rather than a trend reversal.

The most notable divergence of the session is on Scholar Rock (SRRK): Piper Sandler raised its PT to $75, H.C. Wainwright raised to $70, and UBS held at $60 — yet Barclays simultaneously downgraded the stock to Equalweight on valuation concerns after what appears to be an FDA approval catalyst. This classic post-catalyst split (buy the news vs. take profits) is worth watching closely. Similarly, Dave & Buster's saw a wide range of reactions from multiple firms, all negative, suggesting the earnings miss was worse than the Street had modeled.

👉 Vlad's Key Takeaways

• 🟢 Palantir (PLTR) — UBS raises PT to $250 from $220; AI demand momentum keeps the bull case intact.
• 🟢 Eli Lilly (LLY) — Berenberg upgrades to Buy with a $1,400 PT; obesity drug franchise remains a Street favorite.
• 🟢 ResMed (RMD) — RBC upgrades to Outperform; sleep device growth outlook is improving.
• 🔴 Dave & Buster's (PLAY) — BMO cuts PT to $13 from $22, UBS cuts to $9 from $12; multi-firm pile-on after earnings miss signals real fundamental stress.
• 🔴 Rapid7 (RPD) — JPMorgan downgrades to Underweight with $12 PT; transition concerns make this a notable bearish call from a top firm.
• 🟢 Guggenheim Defense Sweep — 14+ defense/aerospace initiations at Buy including NOC, LHX, KTOS, BWXT, HWM; broad sector endorsement.
• 🟡 Scholar Rock (SRRK) — Barclays downgrades on valuation while Piper Sandler raises PT to $75 and H.C. Wainwright to $70; post-FDA approval divergence to watch.
• 🟢 Etsy (ETSY) — Oppenheimer upgrades to Outperform at $90; AI search improvements seen as a genuine growth catalyst.
• 🔴 Comcast (CMCSA) — UBS cuts PT to $27 from $32; broadband subscriber losses remain a structural headwind.
• 🟢 Immix Biopharma (IMMX) — Mizuho raises PT to $26 from $15 (~73% increase); one of the session's boldest biotech target moves.
• 🟢 Enbridge (ENB) — BMO upgrades to Outperform, raising PT; quality and growth visibility driving renewed conviction.
• 🔴 EHang (EH) — Morgan Stanley downgrades to Equalweight; regulatory uncertainty clouds the eVTOL story.
• 🟢 New York Times (NYT) — Guggenheim upgrades to Buy from Neutral, PT $82; digital growth acceleration changes the thesis.
• 🔴 Thor Industries (THO) — BMO cuts PT to $95 from $110; softer RV retail trends weigh on the outlook.
• 🟢 AMD (AMD) — Piper Sandler reiterates Overweight at $600; AI demand keeps the bull case firmly in place.
• 🟢 Agilon Health (AGL) — Bernstein upgrades to Outperform; turnaround progress gaining credibility.
• 🟢 Middleby (MIDD) — JPMorgan upgrades to Overweight, PT $147; portfolio focus and strategic clarity drive the call.
• 🔴 Corning (GLW) — Mizuho cuts PT to $180 from $210; capital needs concerns temper the outlook despite Outperform maintained.
• 🟢 Woodward (WWD) — Guggenheim initiates at Buy, PT $404; aerospace production growth underpins the thesis.
• 🟢 Robinhood (HOOD) — Cantor Fitzgerald reiterates Overweight at $212; prediction market potential adds a new growth angle.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/